The FDA has granted marketing clearance for eNeura’s single-pulse transcranial magnetic stimulation device for use in patients ≥12 years for the acute and prophylactic treatment of migraine.
All articles by Da Hee Han, PharmD
The FDA has taken action against 17 companies that are illegally selling unapproved and/or misbranded products that claim to prevent, treat, or cure Alzheimer disease and other serious diseases and health conditions.
Zogenix announced the submission of a New Drug Application to the FDA for Fintepla oral solution for the treatment of seizures associated with Dravet syndrome.
In preclinical models, the inhibition of phosphorylated STAT3 (p-STAT3) by WP1066 resulted in the direct attack of various tumor cells.
Levetiracetam Injection, an antiepileptic, is indicated as adjunct therapy in patients aged ≥16 years with partial onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures, when oral administration is temporarily not feasible.